Ugo V - Search Results

1

Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.

Ugo V, Marzac C, Teyssandier I, Larbret F, Lécluse Y, Debili N, Vainchenker W, Casadevall N. Ugo V, et al. Exp Hematol. 2004 Feb;32(2):179-87. doi: 10.1016/j.exphem.2003.11.003. Exp Hematol. 2004. PMID: 15102479 Free article.

2

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian JJ, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P. Casadevall N, et al. Among authors: ugo v. N Engl J Med. 2002 Feb 14;346(7):469-75. doi: 10.1056/NEJMoa011931. N Engl J Med. 2002. PMID: 11844847 Free article.

3

[Update on malignant hemopathies].

Ugo V, Legrand O, Delmer A, Rio B, Casadevall N, Marie JP. Ugo V, et al. Bull Cancer. 2002 Jan;89(1):75-88. Bull Cancer. 2002. PMID: 11847029 Free article. Review. French.

4

[The place of growth factors in the treatment of myelodysplastic syndromes].

Ugo V, Casadevall N. Ugo V, et al. Pathol Biol (Paris). 2002 May;50(4):268-74. doi: 10.1016/s0369-8114(02)00301-2. Pathol Biol (Paris). 2002. PMID: 12085672 Review. French.

5

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

James C, Ugo V, Le Couédic JP, Staerk J, Delhommeau F, Lacout C, Garçon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W. James C, et al. Among authors: ugo v. Nature. 2005 Apr 28;434(7037):1144-8. doi: 10.1038/nature03546. Nature. 2005. PMID: 15793561

6

[A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera].

Ugo V, James C, Vainchenker W. Ugo V, et al. Med Sci (Paris). 2005 Jun-Jul;21(6-7):669-70. doi: 10.1051/medsci/2005216-7669. Med Sci (Paris). 2005. PMID: 15985214 Free article. French. No abstract available.

7

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects.

James C, Ugo V, Casadevall N, Constantinescu SN, Vainchenker W. James C, et al. Among authors: ugo v. Trends Mol Med. 2005 Dec;11(12):546-54. doi: 10.1016/j.molmed.2005.10.003. Epub 2005 Nov 3. Trends Mol Med. 2005. PMID: 16271512 Review.

8

Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis.

James C, Delhommeau F, Marzac C, Teyssandier I, Couédic JP, Giraudier S, Roy L, Saulnier P, Lacroix L, Maury S, Tulliez M, Vainchenker W, Ugo V, Casadevall N. James C, et al. Among authors: ugo v. Leukemia. 2006 Feb;20(2):350-3. doi: 10.1038/sj.leu.2404069. Leukemia. 2006. PMID: 16341032 No abstract available.

9

Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells.

Garçon L, Rivat C, James C, Lacout C, Camara-Clayette V, Ugo V, Lecluse Y, Bennaceur-Griscelli A, Vainchenker W. Garçon L, et al. Among authors: ugo v. Blood. 2006 Sep 1;108(5):1551-4. doi: 10.1182/blood-2005-10-009514. Epub 2006 May 9. Blood. 2006. PMID: 16684963 Free article.

10

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera.

Dupont S, Massé A, James C, Teyssandier I, Lécluse Y, Larbret F, Ugo V, Saulnier P, Koscielny S, Le Couédic JP, Casadevall N, Vainchenker W, Delhommeau F. Dupont S, et al. Among authors: ugo v. Blood. 2007 Aug 1;110(3):1013-21. doi: 10.1182/blood-2006-10-054940. Epub 2007 Mar 27. Blood. 2007. PMID: 17389763 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters